Clinical trial

Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.

NCT00247390 · Takeda, Industry · Completed

Key facts

NCT number NCT00247390
Title Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.
Official title A Randomised, Double-blind, Placebo-controlled Study to Determine the Long-term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.
Lead sponsor Takeda, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Chronic Insomnia
Intervention type Drug
Interventions Ramelteon, Placebo
Enrollment 451
Start date Jul 1, 2005
Primary completion Dec 1, 2006
Completion Dec 1, 2006
First posted Nov 1, 2005
Last update posted Jun 3, 2010
Countries Australia, Belgium, Czechia, Finland, France, Germany, Italy, Russia, United States

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies